480 studies found for:    "Homologous wasting disease"
Show Display Options
Rank Status Study
1 Recruiting Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)
Conditions: Chronic Graft-Versus-Host Disease;   Acute Graft-Versus-Host Disease;   Steroid Refractory Graft-Versus-Host Disease
Interventions: Drug: Rapamycin;   Other: T regulatory cells
2 Completed A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-
Conditions: Bone Marrow Transplantation;   Graft Versus Host Disease;   Graft-Versus-Host Disease;   Graft-Vs-Host Disease
Intervention: Drug: Tacrolimus
3 Recruiting Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
Conditions: Graft Versus Host Disease;   Steroid Refractory GVHD;   Acute GVH Disease
Intervention: Drug: Infliximab and Basiliximab
4 Active, not recruiting Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease
Conditions: Graft vs Host Disease;   Chronic Graft vs Host Disease;   cGVHD
Intervention:
5 Unknown  Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.
Conditions: Graft Versus Host Disease;   Chronic and Expanded Graft Versus Host Disease;   Immune System Diseases
Interventions: Drug: Conventional treatment;   Other: Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue.
6 Not yet recruiting An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease
Conditions: Chronic Graft-versus-Host-Disease;   Oral Mucosal Disease Due to Graft-versus-host Disease
Intervention: Drug: Sirolimus
7 Completed A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients
Conditions: Bone Marrow Transplantation;   Graft Versus Host Disease;   Graft-Vs-Host Disease;   Graft-Versus-Host Disease
Intervention: Drug: Tacrolimus
8 Completed Randomized Study of Oral Beclomethasone Dipropionate With Ten Days of Prednisone for Treatment of Gastrointestinal GVHD
Conditions: Graft Vs Host Disease;   Gastrointestinal Graft-Versus-Host Disease
Intervention: Drug: Oral beclomethasone dipropionate (drug)
9 Recruiting Pomalidomide for Chronic Graft-versus-Host Disease
Conditions: Graft vs Host Disease;   Graft-Versus-Host Disease
Intervention: Drug: Pomalidomide
10 Completed Experience of Having Chronic Graft-Versus-Host Disease
Condition: Graft-Versus-Host Disease
Interventions: Behavioral: Interview;   Behavioral: Questionnaire
11 Withdrawn Natural History and Pathophysiology of Gastrointestinal Graft-versus-Host Disease
Condition: Graft-Versus-Host-Disease
Intervention:
12 Enrolling by invitation Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease
Condition: Graft-Versus-Host Disease
Intervention:
13 Completed Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease
Condition: Graft vs Host Disease
Intervention: Drug: Rituximab
14 Recruiting Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease
Condition: Acute Graft Versus Host Disease
Intervention: Drug: Tocilizumab
15 Recruiting Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Condition: Graft Versus Host Disease
Intervention: Drug: Ibrutinib
16 Terminated A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)
Condition: Graft Versus Host Disease
Intervention: Drug: Rituximab
17 Recruiting Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease
Condition: Chronic Graft Versus Host Disease
Intervention: Drug: Ofatumumab
18 Active, not recruiting Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
Condition: Graft vs. Host Disease
Interventions: Drug: Ustekinumab;   Drug: Placebo
19 Active, not recruiting Atorvastatin for the Prophylaxis of Acute Graft-versus-host Disease in Patients Undergoing Matched Sibling Allogeneic Transplantation
Condition: Graft vs Host Disease
Intervention: Drug: Atorvastatin calcium (Lipitor)
20 Recruiting Intra Arterial (IA) Steroids Infusion for Hepatic Acute Hepatic Graft Versus Host Disease (aGVHD)
Condition: Acute Graft Versus Host Disease
Intervention: Drug: Methylprednisolone (Intra-arterial continuous infusion of corticosteroids)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years